SEC Form 4 · accession 0001213900-18-000085
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Green
Officer — Chief Financial Officer
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2018 | A | 75,000 | — | A | 75,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These are restricted shares that vest on January 2, 2028, subject to earlier vesting in certain situations.